Abiopharma

🔍 CHEUNG MARTINA (Director)

Company: S&P Global Inc. (SPGI)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 2,322 shares of Common Stock at $429.93 per share (Direct)
  Date: 2026-04-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 27,518.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 891 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 891.00 | Footnotes: F2, F3, F3
• Holds 3,381 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 3,381.00 | Footnotes: F2, F4, F4
• Holds 10,358 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 10,358.00 | Footnotes: F2, F5, F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $429.92 to $430.25, inclusive. The reporting person undertakes to provide to S&P Global Inc., any security holder of S&P Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
• F2: Each restricted stock unit represents a contingent right to receive one share of SPGI common stock.
• F3: As previously reported, the reporting person was granted 2,619 restricted stock units on 03/01/2024, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2024 and 33% on 12/31/2025 and the remaining 34% will vest on 12/31/2026. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.
• F4: As previously reported, the reporting person was granted 5,046 restricted stock units on 03/01/2025, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2025 and will vest 33% on 12/31/2026 and 34% on 12/31/2027. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.
• F5: As previously reported, the reporting person was granted 10,358 restricted stock units on 03/01/2026, subject to 3-year vesting. The restricted stock units will vest 33% on 03/01/2027, 33% on 03/01/2028 and 34% on 03/01/2029.